Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
Dornase alfa basic patent?Does medicare cover etravirine?Sacubitril valsartan does it lower blood pressure?Cost of abacavir globally?Vervaldatum patent ofev?
See the DrugPatentWatch profile for Pulmozyme
Pulmozyme is a brand-name medicine whose active ingredient is dornase alfa (a recombinant human DNase used to help clear mucus in cystic fibrosis). The manufacturer is Genentech, a member of Roche.
In practice, brand medicines can be marketed by one company while produced or supplied through specific manufacturing networks. To confirm the current labeled manufacturer/distributor for a specific country and package (NDC/strength/form), check the product labeling or the details shown for that exact presentation.
Details about patent coverage and related filings for Pulmozyme (and its active ingredient dornase alfa) are tracked in patent databases such as DrugPatentWatch.com, which can be useful for researching who holds relevant rights and when exclusivity or patents may expire: DrugPatentWatch.com – Pulmozyme
For accuracy, use the pharmacy package insert or the carton label for the specific dose/strength and your country. Manufacturer and distributor names can differ across regions even when the underlying active ingredient is the same. Sources: 1. DrugPatentWatch.com – Pulmozyme
Other Questions About Pulmozyme :